TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Pharmaceutical Preparations
Latest Price
$39.25
TTM P/E
64.34
Normalized P/E
--
Div Yield
--
Book Value
6.68
P/B Ratio
5.87
Valuation metrics
adjust assumptions →EPS: $1.21
Book value / share: $6.80
Formula: √(22.5 × EPS × BVPS)
Graham Number
$13.61
65% downside
Base FCF: $842M (median of recent 5yr)
Growth: 7%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$15.79
60% downside
EPS: $1.21
Target P/E: 64×
Formula: EPS × P/E
P/E Fair Value
$77.44
+97% upside
Institutional Ownership
64.1% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 63.89M | $2.16B | 5.51% | -1.24M | 2026-06-30 |
| Harel Insurance Investments & Financial Services Ltd. | 48.14M | $1.63B | 4.15% | +2.18M | 2026-06-30 |
| Phoenix Financial Ltd. | 42.93M | $1.45B | 3.70% | +156.0K | 2026-06-30 |
| WCM INVESTMENT MANAGEMENT, LLC | 41.32M | $1.38B | 3.56% | +494.6K | 2026-06-30 |
| Clal Insurance Enterprises Holdings Ltd | 40.60M | $1.37B | 3.50% | +2.15M | 2026-06-30 |
| MENORA MIVTACHIM HOLDINGS LTD. | 39.85M | $1.35B | 3.44% | +228.0K | 2026-06-30 |
| Migdal Insurance & Financial Holdings Ltd. | 38.92M | $1.32B | 3.36% | +1.02M | 2026-06-30 |
| NORGES BANK | 32.30M | $1.09B | 2.78% | -2.88M | 2026-06-30 |
| FMR LLC | 30.26M | $1.02B | 2.61% | -2.87M | 2026-06-30 |
| Lingotto Investment Management LLP | 20.21M | $684.0M | 1.74% | -7.56M | 2026-06-30 |